Literature DB >> 6121031

A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats.

F Pisani, A Fazio, G Oteri, R Di Perri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6121031     DOI： 10.1111/j.2042-7158.1982.tb04676.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  7 in total

1.  Valpromide inhibits human epoxide hydrolase.

Authors:  G M Pacifici; M Franchi; C Bencini; A Rane
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

Review 2.  Clinical pharmacology of valpromide.

Authors:  M Bialer
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

3.  Intra-daily oscillations in dipropylacetic acid plasma levels with two or three daily doses of dipropylacetamide in epileptic patients.

Authors:  F Pisani; E Spina; C Trunfio; A Fazio; G Oteri; R Di Perri
Journal:  Ital J Neurol Sci       Date:  1983-06

4.  Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide.

Authors:  F Pisani; A Fazio; G Oteri; E Spina; E Perucca; L Bertilsson
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

5.  Pharmacokinetics of valpromide after oral administration of a solution and a tablet to healthy volunteers.

Authors:  M Bialer; A Rubinstein; I Raz; O Abramsky
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Valpromide is a poor inhibitor of the cytosolic epoxide hydrolase.

Authors:  G M Pacifici; A Temellini; L Giuliani; A Rane; H Thomas; F Oesch
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

7.  EEG effects of i.v. infusion of pentylenetetrazol in rats: a model for screening and classifying antiepileptic compounds.

Authors:  V Santucci; M Fournier; P Keane; J Simiand; J C Michaud; M Morre; K Biziere
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.